
About LifeHealthcare:
LifeHealthcare, an EBOS MedTech company, is one of Australia and New Zealand’s leading independent medical technology distributors. Our strength lies in offering the scale of our clinical suppliers with the support of local experts in both countries, ensuring that we understand and meet our local healthcare systems’ unique needs.
LifeHealthcare is focused on providing access to world-leading medical devices and technology for Australian and New Zealand patients whilst ensuring long-term economic sustainability for our healthcare system. LifeHealthcare has a broad portfolio of products in various channels including Spine, Orthopaedics (Recon, Extremities and Regen), Enabling Technology, Robotics, Plastics & Reconstructive Surgery, Neurovascular Intervention, Abdo-Pelvic and Neurosurgery, OR capital and scope repair, to name a few.
Our passion is health. Our purpose is helping to make life better for others.

About DePuy Synthes:
DePuy Synthes, provides one of the most comprehensive orthopaedics portfolios in the world that helps heal and restore movement for the millions of patients we serve. DePuy Synthes solutions, in specialties including joint reconstruction, trauma, extremities, craniomaxillofacial, and sports medicine, in addition to the VELYS™ Digital Surgery portfolio, are designed to advance patient care while delivering clinical and economic value to health care systems worldwide.
Building on our proud product innovation and legacy of industry firsts, we are reimagining the orthopaedic landscape with new advancements in medical technologies and digital surgery across the entire continuum of care to Keep People Moving today and tomorrow. For more information, visit www.jnjmedicaldevices.com/en-au/companies/depuy-synthes.

About Medacta:
Medacta is a dynamic, solid, and fast-growing global key player specializing in the design, production, and distribution of innovative, personalized, and sustainable solutions for joint replacement, sports medicine, and spine surgery. Founded in 1999 in Switzerland by a patient, Medacta is committed to responsibly improving the care and well-being of patients while creating value for healthcare systems. Through close collaboration with expert surgeons globally, continuous investments in R&D, and the adoption of cutting-edge technologies, Medacta’s sustainable innovation prioritizes minimally invasive surgery and personalized solutions for every patient. Through the M.O.R.E. Institute, Medacta supports surgeons with a comprehensive and tailored program dedicated to the advancement of medical education. Medacta is headquartered in Castel San Pietro, Switzerland, and operates in over 70 countries.